# Radiation Therapy With or Without Antiandrogen Therapy in Treating Patients With Stage I or Stage II Prostate Cancer

> **NCT00002597** · PHASE3 · COMPLETED · sponsor: **Radiation Therapy Oncology Group** · enrollment: 2028 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **DRUG:** flutamide
- **DRUG:** Zoladex
- **DRUG:** Lupron
- **RADIATION:** radiation therapy

## Key facts

- **NCT ID:** NCT00002597
- **Lead sponsor:** Radiation Therapy Oncology Group
- **Sponsor class:** NETWORK
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1994-10
- **Primary completion:** 2011-07
- **Final completion:** 2018-05-14
- **Target enrollment:** 2028 (ACTUAL)
- **Last updated:** 2018-06-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00002597

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00002597, "Radiation Therapy With or Without Antiandrogen Therapy in Treating Patients With Stage I or Stage II Prostate Cancer". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00002597. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*